These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2211035

  • 1. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage.
    Silverman SE, Hart WM, Gordon MO, Kilo C.
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1895-902. PubMed ID: 2211035
    [Abstract] [Full Text] [Related]

  • 2. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
    Katz B.
    Trans Am Ophthalmol Soc; 1995 Sep; 93():685-708. PubMed ID: 8719696
    [Abstract] [Full Text] [Related]

  • 3. Color vision defect type and spatial vision in the optic neuritis treatment trial.
    Schneck ME, Haegerstrom-Portnoy G.
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia].
    Ayed S, Jeddi A, Kallal Z.
    J Fr Ophtalmol; 1990 Oct; 13(10):506-10. PubMed ID: 2081841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
    Utku D, Atmaca LS.
    Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
    [Abstract] [Full Text] [Related]

  • 9. High-pass resolution perimetry in optic neuritis.
    Wall M.
    Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2525-9. PubMed ID: 1869407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Foveal color and luminance sensitivity losses in glaucoma.
    Kelly JP, Fourman SM, Jindra LF.
    Ophthalmic Surg Lasers; 1996 Mar; 27(3):179-87. PubMed ID: 8833122
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--II. Colour vision defects acquired in diabetic retinopathy.
    Birch J, Dain SJ.
    Ophthalmic Physiol Opt; 1987 Mar; 7(3):281-91. PubMed ID: 3500447
    [Abstract] [Full Text] [Related]

  • 15. [Dyschromatopsia: manifestation or epiphenomenon in the course of diabetic neuropathy].
    Doucet J, Chassagne P, Trivalle C, Ozenne G, Retout A, Parain D, Bercoff E, Courtois H, Schrub JC.
    Diabete Metab; 1994 Mar; 20(4):420-4. PubMed ID: 7843474
    [Abstract] [Full Text] [Related]

  • 16. Glaucomatous visual field damage. Luminance and color-contrast sensitivities.
    Hart WM, Silverman SE, Trick GL, Nesher R, Gordon MO.
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):359-67. PubMed ID: 2303333
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A multifactorial etiologic approach to diabetic dyschromatopsia. Study of 100 diabetics].
    Doucet J, Retout A, Poutrain JR, Ozenne G, Leprince MP, Parain D, Brasseur G, Schrub JC.
    Diabete Metab; 1991 Feb; 17(1):31-7. PubMed ID: 1868958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.